Therapeutic potential of phytochemicals for cystic fibrosis

被引:4
|
作者
Baharara, Hamed [1 ]
Kesharwani, Prashant [2 ,3 ]
Johnston, Thomas P. [4 ]
Sahebkar, AmirHossein [5 ,6 ,7 ]
机构
[1] Mashhad Univ Med Sci, Sch Pharm, Dept Clin Pharm, Mashhad, Iran
[2] Jamia Hamdard, Sch Pharmaceut Educ & Res, Dept Pharmaceut, New Delhi, India
[3] Saveetha Inst Med & Tech Sci, Saveetha Dent Coll, Ctr Transdisciplinary Res, Dept Pharmacol, Chennai, India
[4] Univ Missouri Kansas City, Sch Pharm, Div Pharmacol & Pharmaceut Sci, Kansas City, MO USA
[5] Mashhad Univ Med Sci, Pharmaceut Technol Inst, Biotechnol Res Ctr, Mashhad, Iran
[6] Mashhad Univ Med Sci, Appl Biomed Res Ctr, Mashhad, Iran
[7] Mashhad Univ Med Sci, Sch Pharm, Dept Biotechnol, Mashhad, Iran
关键词
baicalein; capsaicin; coumarin; curcumin; cystic fibrosis; genistein; phytomedicine; quercetin; resveratrol; TRANSMEMBRANE CONDUCTANCE REGULATOR; NATURAL COMPOUND CURCUMIN; CHLORIDE-CHANNEL; WILD-TYPE; SURFACE EXPRESSION; NUCLEOTIDE-BINDING; DELTA-F508; CFTR; CELL-CULTURE; IN-VITRO; GENISTEIN;
D O I
10.1002/biof.1960
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The aim of this review was to review and discuss various phytochemicals that exhibit beneficial effects on mutated membrane channels, and hence, improve transmembrane conductance. These therapeutic phytochemicals may have the potential to decrease mortality and morbidity of CF patients. Four databases were searched using keywords. Relevant studies were identified, and related articles were separated. Google Scholar, as well as gray literature (i.e., information that is not produced by commercial publishers), were also checked for related articles to locate/identify additional studies. The relevant databases were searched a second time to ensure that recent studies were included. In conclusion, while curcumin, genistein, and resveratrol have demonstrated effectiveness in this regard, it should be emphasized that coumarins, quercetin, and other herbal medicines also have beneficial effects on transporter function, transmembrane conductivity, and overall channel activity. Additional in vitro and in vivo studies should be conducted on mutant CFTR to unequivocally define the mechanism by which phytochemicals alter transmembrane channel function/activity, since the results of the studies evaluated in this review have a high degree of heterogenicity and discrepancy. Finally, continued research be undertaken to clearly define the mechanism(s) of action and the therapeutic effects that therapeutic phytochemicals have on the symptoms observed in CF patients in an effort to reduce mortality and morbidity.
引用
收藏
页码:984 / 1009
页数:26
相关论文
共 50 条
  • [21] PPARγ as a therapeutic target in cystic fibrosis
    Dekkers, Johanna F.
    van der Ent, Cornelis K.
    Kalkhoven, Eric
    Beekman, Jeffrey M.
    TRENDS IN MOLECULAR MEDICINE, 2012, 18 (05) : 283 - 291
  • [22] THERAPEUTIC MANAGEMENT OF CYSTIC-FIBROSIS
    KUHN, RJ
    NAHATA, MC
    CLINICAL PHARMACY, 1985, 4 (05): : 555 - 565
  • [23] New therapeutic developments in cystic fibrosis
    Bui, S.
    Macey, J.
    Fayon, M.
    Bihouee, T.
    Burgel, P. -R.
    Colomb, V.
    Corvol, H.
    Durieu, I.
    Hubert, D.
    Marguet, C.
    Mas, E.
    Munck, A.
    Murris-Espin, M.
    Reix, R.
    Sermet-Gaudelus, I.
    ARCHIVES DE PEDIATRIE, 2016, 23 : S47 - S53
  • [24] Therapeutic advances in cystic fibrosis in 2014
    Durupt, S.
    Mazur, S.
    Reix, P.
    REVUE DE PNEUMOLOGIE CLINIQUE, 2016, 72 (01) : 77 - 86
  • [25] Disparities and therapeutic advances in cystic fibrosis
    Palla, John B.
    PEDIATRIC PULMONOLOGY, 2024, 59 (12) : 3812 - 3818
  • [26] THERAPEUTIC REGIMEN FOR PATIENTS WITH CYSTIC FIBROSIS
    MATTHEWS, LW
    DOERSHUK, CF
    WISE, M
    EDDY, G
    SPECTOR, S
    NUDELMAN, H
    JOURNAL OF PEDIATRICS, 1964, 65 (04): : 558 - +
  • [27] Therapeutic guidelines for the treatment of cystic fibrosis
    Becheva, Maria
    Atanasov, Petar
    PHARMACIA, 2021, 68 (01) : 151 - 154
  • [28] TGFβ as a therapeutic target in cystic fibrosis
    Kramer, Elizabeth L.
    Clancy, John P.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2018, 22 (02) : 177 - 189
  • [29] New Therapeutic Approaches in Cystic Fibrosis
    Fakioglu, Dolunay Merve
    Altun, Beril
    TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 17 (06) : 686 - 697
  • [30] EVALUATION OF A CYSTIC FIBROSIS THERAPEUTIC REGIMEN
    MATTHEWS, LW
    EDDY, GE
    WISE, M
    AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1960, 100 (05): : 734 - 735